CAS: 331770-21-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide REF: AN-AG01EPC8CAS: 331770-21-9 | 97% | 170,00 €~1.099,00 € | Jue 02 May 24 |
 | Aurora kinase inhibitor-2 REF: TM-T9040CAS: 331770-21-9 | 99.15% | 122,00 €~1.356,00 € | Mié 08 May 24 |
![N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide](https://static.cymitquimica.com/products/AN/thumb/AG01EPC8.jpg)
N-[4-[(6,7-dimethoxy-4-quinazolinyl)amino]phenyl]-benzamide
CAS:331770-21-9
Fórmula:
C23H20N4O3
Pureza:
97%
Forma y color:
Solid
Peso molecular:
400.4299
Ref: AN-AG01EPC8
| 5mg | 170,00 € | |
| 10mg | 204,00 € | |
| 25mg | 540,00 € | |
| 50mg | 647,00 € | |
| 100mg | 1.099,00 € |
Entrega estimada en Estados Unidos, el Jueves 2 de Mayo de 2024
Aurora kinase inhibitor-2
CAS:331770-21-9
Aurora kinase inhibitor-2 (IUN-70219) is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A …
Fórmula:
C23H20N4O3
Pureza:
99.15%
Forma y color:
Solid
Peso molecular:
400.43
Ref: TM-T9040
| 1mg | 122,00 € | |
| 5mg | 269,00 € | |
| 10mg | 440,00 € | |
| 25mg | 722,00 € | |
| 50mg | 1.012,00 € | |
| 100mg | 1.356,00 € | |
| 1ml*10 (DMSO) | 335,00 € |
Entrega estimada en Estados Unidos, el Miércoles 8 de Mayo de 2024
